Related Experiment Video
Updated: Jun 19, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Intravenous thrombolysis in stroke attributable to cervical artery dissection
Stefan T Engelter1, Matthieu P Rutgers, Florian Hatz
1Stroke Units and Department of Neurology, University Hospitals Basel, Switzerland. sengelter@uhbs.ch
Intravenous thrombolysis (IVT) for cervical artery dissection (CAD) shows less favorable outcomes compared to other stroke causes. However, similar rates of bleeding and recurrent stroke suggest IVT remains a viable treatment option for CAD patients.
Area of Science:
- Neurology
- Vascular Medicine
- Emergency Medicine
Background:
- Cervical artery dissection (CAD) is a significant cause of stroke in younger adults.
- The efficacy and safety of intravenous thrombolysis (IVT) in CAD patients remain under investigation.
- Previous studies suggest IVT benefits stroke patients regardless of etiology.
Purpose of the Study:
- To evaluate the outcomes and complications of IVT in patients with CAD compared to non-CAD stroke patients.
- To determine if IVT is a safe and effective treatment for stroke secondary to CAD.
- To identify factors contributing to potential differences in outcomes.
Main Methods:
- Retrospective analysis of the Swiss IVT databank.
- Comparison of IVT-treated CAD patients (n=55) with non-CAD patients (n=1007).
- Primary outcomes included favorable 3-month outcome (modified Rankin Scale score ≤1), intracranial hemorrhage, and recurrent ischemic stroke.
Main Results:
- CAD patients were younger but had similar stroke severity and treatment times compared to non-CAD patients.
- Favorable 3-month outcome was less frequent in CAD patients (36%) versus non-CAD patients (44%), particularly after age, gender, and NIHSS adjustment (OR, 0.50; P=0.03).
- Rates of intracranial hemorrhage (14% vs. 14%) and recurrent ischemic stroke (1.8% vs. 3.7%) were similar between CAD and non-CAD groups.
Conclusions:
- IVT-treated CAD patients experience less favorable functional recovery compared to non-CAD patients.
- The similar rates of intracranial hemorrhage and recurrent ischemic stroke suggest these complications do not explain the outcome disparity.
- IVT should not be withheld from patients with suspected CAD, as potential factors like hemodynamic compromise or tandem occlusions may influence outcomes.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Transient Ischemic Attack l: Introduction
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction

